Eli Lilly’s weight-loss pill didn’t work so well, and the stock is tumbling
Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Do you want to build your own blog website similar to this one? Contact us
